Q4 2015 13F Holders as of 12/31/2015
-
Type / Class
-
Equity / Common Stock par value $0.012 per share
-
Shares outstanding
-
41M
-
Number of holders
-
23
-
Total 13F shares, excl. options
-
210K
-
Shares change
-
+38.1K
-
Total reported value, excl. options
-
$1.78M
-
Value change
-
+$387K
-
Put/Call ratio
-
0.44
-
Number of buys
-
10
-
Number of sells
-
-8
-
Price
-
$8.55
Significant Holders of ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) as of Q4 2015
29 filings reported holding ORMP - ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share as of Q4 2015.
ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) has 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 210K shares
of 41M outstanding shares and own 0.51% of the company stock.
Largest 10 shareholders include TOCQUEVILLE ASSET MANAGEMENT L.P. (70K shares), BARCLAYS PLC (29.9K shares), GROUP ONE TRADING, L.P. (17.8K shares), GREYLIN INVESTMENT MANGEMENT INC (15.2K shares), HSBC HOLDINGS PLC (15K shares), Cutler Group LP (14.5K shares), MILLENNIUM MANAGEMENT LLC (14.4K shares), WELLS FARGO & COMPANY/MN (10.3K shares), FineMark National Bank & Trust (3.47K shares), and MORGAN STANLEY (3.31K shares).
This table shows the top 23 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.